A review on Pushkarmula - The effective Anti-Ischemic Drug
Dakhole S.1*, Mishra B.2, Purohit H.3
DOI:
1* Sapana S. Dakhole, First Year Post Graduate Scholar, Post Graduate Department of Samhita Siddhanta, Shri Ayurved Mahavidyala, Nagpur, Maharashtra, India.
2 Brijesh R. Mishra, Professor and HOD, Post Graduate Department of Samhita Siddhanta, Shri Ayurved Mahavidyala, Nagpur, Maharashtra, India.
3 Harish J. Purohit, Associate Professor, Post Graduate Department of Samhita Siddhanta, Shri Ayurved Mahavidyala, Nagpur, Maharashtra, India.
Hridroga is a disease of Marma (vital organ) which is the seat of many vital activities. In Ayurveda all the painful heart disease comes under the broad classification of Hridroga. In modern science myocardial ischemia is one of the worst painful conditions among the heart diseases Myocardial ischemic develops when Coronary blood supply to the myocardium is reduced, either in terms of absolute flow rate. (Low-flow or no flow ischemia) or relative to increased tissue demand. Inula racemosa Hook, F (Asteraceae) Commonly known as Pushkarmula is one of the herbs mentioned in all Ayurvedic scriptures. The great Sage Charaka has categorized it as Hikkanigrahana - stops hiccup a Svasahara - alleviates the breathlessness in asthma. It has also anti-inflammatory, Cardiovascular hypoglycemic, antianginal, analgesic and antibacterial Properties. This article is an attempt to collect and review all the data concerning systemic scientific study of ethnopharmacology of Inula racemosa and its cardio protective functions.
Keywords: Hridroga, Pushkarmula, Ayurveda, anti-ischemic, Hikkanigrahana
Corresponding Author | How to Cite this Article | To Browse |
---|---|---|
Email: |
, First Year Post Graduate Scholar, Post Graduate Department of Samhita Siddhanta, Shri Ayurved Mahavidyala, Nagpur, Maharashtra, India.Sapana S. Dakhole, Brijesh R. Mishra, Harish J. Purohit, A review on Pushkarmula - The effective Anti-Ischemic Drug. J Ayu Int Med Sci. 2022;7(3):127-131. Available From https://jaims.in/jaims/article/view/1794 |